Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
272.66
+0.94 (0.35%)
Nov 9, 2026, 2:48 PM EST - Market open
Cardinal Health Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 63,022 | 55,638 | 40,098 | 23,948 | 24,078 | 14,240 | |
Market Cap Growth | 34.79% | 38.76% | 67.44% | -0.54% | 69.09% | -14.04% |
Enterprise Value | 66,573 | 60,777 | 45,501 | 26,087 | 24,824 | 17,500 |
Last Close Price | 271.72 | 236.49 | 165.38 | 95.09 | 90.08 | 48.53 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 35.31 | 32.46 | 25.69 | 28.11 | 72.96 | - |
Forward PE | 20.69 | 20.44 | 18.60 | 13.43 | 14.77 | 9.77 |
PS Ratio | 0.25 | 0.22 | 0.18 | 0.11 | 0.12 | 0.08 |
PB Ratio | - | -20.42 | -15.22 | -7.46 | -8.14 | -20.17 |
P/FCF Ratio | 12.92 | 12.30 | 21.67 | 7.37 | 10.19 | 5.11 |
P/OCF Ratio | 11.31 | 10.75 | 16.73 | 6.37 | 8.47 | 4.49 |
PEG Ratio | 1.38 | 1.20 | 1.39 | 1.01 | 1.06 | 11.42 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.26 | 0.24 | 0.20 | 0.12 | 0.12 | 0.10 |
EV/EBITDA Ratio | 15.24 | 14.32 | 13.89 | 9.19 | 10.01 | 7.48 |
EV/EBIT Ratio | 19.57 | 18.48 | 18.30 | 12.25 | 13.88 | 10.62 |
EV/FCF Ratio | 13.65 | 13.43 | 24.60 | 8.02 | 10.51 | 6.28 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | -3.08 | -3.67 | -3.56 | -1.78 | -1.78 | -8.28 |
Debt / EBITDA Ratio | 1.88 | 2.20 | 2.70 | 1.91 | 2.02 | 2.37 |
Debt / FCF Ratio | 1.80 | 2.21 | 5.08 | 1.75 | 2.23 | 2.10 |
Net Debt / Equity Ratio | -1.24 | -1.89 | -2.09 | -0.11 | -0.40 | -1.60 |
Net Debt / EBITDA Ratio | 0.81 | 1.21 | 1.68 | 0.13 | 0.48 | 0.48 |
Net Debt / FCF Ratio | 0.73 | 1.14 | 2.98 | 0.11 | 0.51 | 0.41 |
Asset Turnover | 4.49 | 4.61 | 4.53 | 5.13 | 4.70 | 4.11 |
Inventory Turnover | 13.78 | 14.33 | 13.49 | 14.12 | 12.48 | 11.57 |
Quick Ratio | 0.43 | 0.43 | 0.44 | 0.49 | 0.45 | 0.50 |
Current Ratio | 0.89 | 0.88 | 0.94 | 0.98 | 1.00 | 1.08 |
Return on Equity (ROE) | - | - | - | - | - | -172.24% |
Return on Assets (ROA) | 3.72% | 3.72% | 3.16% | 3.01% | 2.56% | 2.33% |
Return on Invested Capital (ROIC) | 20.50% | 18.67% | 15.66% | 15.85% | 7.79% | 17.88% |
Return on Capital Employed (ROCE) | 25.90% | 24.50% | 17.50% | 22.50% | 18.60% | 12.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 2.83% | 3.08% | 3.89% | 3.56% | 1.37% | -6.59% |
FCF Yield | 7.74% | 8.13% | 4.61% | 13.58% | 9.81% | 19.58% |
Dividend Yield | 0.76% | 0.86% | 1.21% | 2.04% | 2.07% | 3.77% |
Payout Ratio | 26.72% | 28.65% | 31.65% | 58.57% | 159.09% | - |
Buyback Yield / Dilution | 2.08% | 2.07% | 2.02% | 5.73% | 6.09% | 5.10% |
Total Shareholder Return | 2.83% | 2.92% | 3.23% | 7.77% | 8.16% | 8.88% |